US Ebola case boosts biotechs with treatments
October 01, 2014 at 06:07 AM EDT
Sentiment in U.S. stock futures overall was dampened early Wednesday after the U.S. confirmed its first case of Ebola. But biotech stocks were stronger.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|